The American Journal of Managed Care11 小时
Decisions and Precision in Value-Based Cancer Care
An Institute for Value-Based Medicine regional event in Houston, Texas, covered inconsistencies with the integration of precision medicine in oncology practices, the evolution of treatment for ...
GORTEC Announces New Trial Success for Head and Neck Cancer Treatment
GORTEC, known as Head and Neck Radiation Oncology Group, today announced that the randomized Phase 3 NIVOPOSTOP GORTEC ...
Pharmaceutical Technology2 天
PF-07921585 by Pfizer for Metastatic Colorectal Cancer: Likelihood of Approval
PF-07921585 is under clinical development by Pfizer and currently in Phase I for Metastatic Colorectal Cancer.
Pharmaceutical Technology2 天
XB-010 by Exelixis for Triple-Negative Breast Cancer (TNBC): Likelihood of Approval
XB-010 is under clinical development by Exelixis and currently in Phase I for Triple-Negative Breast Cancer (TNBC).